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ABSTRACT  18 
The apolipoprotein B editing enzyme catalytic subunit 3 (APOBEC3) is a family of DNA cytosine 19 
deaminases that mutate and inactivate viral genomes by single-strand DNA editing, thus providing an 20 
innate immune response against a wide range of DNA and RNA viruses. In particular, APOBEC3A 21 
(A3A), a member of the APOBEC3 family, is induced by human cytomegalovirus (HCMV) in decidual 22 
tissues where it efficiently restricts HCMV replication, thereby acting as an intrinsic innate immune 23 
effector at the maternal-fetal interface. However, the widespread incidence of congenital HCMV 24 
infection implies that HCMV has evolved to counteract APOBEC3-induced mutagenesis through 25 
mechanisms that still remain to be fully established. Here, we have assessed gene expression and 26 
deaminase activity of various APOBEC3 gene family members in HCMV-infected primary human 27 
foreskin fibroblasts (HFFs). Specifically, we show that APOBEC3G (A3G) and to a lesser degree A3F, 28 
but not A3A, gene products are upregulated in HCMV-infected HFFs. We also show that HCMV-29 
mediated induction of A3G expression is mediated by interferon- (IFN-β), which is produced early 30 
during HCMV infection. However, knockout or overexpression of A3G does not affect HCMV 31 
replication, indicating that A3G is not a restriction factor for HCMV. Finally, through a bioinformatics 32 
approach, we show that HCMV has evolved mutational robustness against IFN-β by limiting the 33 
presence of A3G hotspots in essential open reading frames (ORFs) of its genome. Overall, our findings 34 
uncover a novel immune evasion strategy by HCMV with profound implications for HCMV infections.  35 
 36 
 37 
 38 
 39 
 40 
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IMPORTANCE  42 
APOBEC3 family of proteins plays a pivotal role in intrinsic immunity defense mechanisms against 43 
multiple viral infections, including retroviruses, through the deamination activity. However, the 44 
currently available data on APOBEC3 editing mechanisms upon HCMV infection remain unclear. 45 
In the present study we show that particularly APOBEC3G (A3G) member of the deaminase family is 46 
strongly induced upon infection with HCMV in fibroblasts and its upregulation is mediated by IFN-β. 47 
Furthermore, we were able to demonstrate that neither A3G knock out nor its overexpression appear to 48 
modulate HCMV replication, indicating that A3G does not inhibit HCMV replication. This may be 49 
explained by HCMV escape strategy from A3G activity through depletion of the preferred nucleotide 50 
motifs (hotspots) from its genome. The results may shed light on antiviral potential of APOBEC3 51 
activity during HCMV infection, as well as the viral counteract mechanisms under A3G-mediated 52 
selective pressure.  53 
  54 
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INTRODUCTION 55 
Human cytomegalovirus (HCMV) is a ubiquitous opportunistic β-herpesvirus, which, despite 56 
infecting the vast majority of the world’s population, can rarely cause symptomatic diseases in healthy, 57 
immunocompetent individuals (1). However, reactivation of latent HCMV infection in 58 
immunocompromised hosts (e.g. transplant recipients) may result in life-threatening diseases. 59 
Likewise, HCMV congenital infection can lead to abortion or dramatic disabilities in the infant 60 
including deafness and mental retardation (2). A hallmark of HCMV pathogenesis is its ability to 61 
productively replicate in an exceptionally broad range of target cells such as epithelial, smooth muscle 62 
and endothelial cells as well as fibroblasts (3, 4). 63 
A central component of innate antiviral immunity against HCMV is the rapid activation of 64 
multiple interferon (IFN) signaling pathways that upregulate the expression of a rising number of 65 
restriction factors committed to counteract virus replication. Such intrinsic immune mechanisms 66 
therefore provide a frontline antiviral defense mediated by constitutively expressed proteins, already 67 
present and active before the virus enters a cell (5, 6). These intrinsic immune effectors, which were 68 
initially discovered as being active against retroviruses, include the apolipoprotein B editing catalytic 69 
subunit-like 3 (APOBEC3) family of cytidine deaminases and tetherin, an IFN-inducible protein whose 70 
expression blocks the release of human immunodeficiency virus type 1 (HIV-1) (7). However, it soon 71 
became apparent that such effectors were also active against other viruses, such as vesicular stomatitis 72 
virus, filoviruses, influenza virus and hepatitis C virus (8). Moreover, other proteins such as PML, 73 
hDaxx, Sp100 (9, 10), viperin and IFI16 were subsequently identified as restriction factors mediating 74 
the intrinsic immune response against HCMV infection (11, 12).  75 
The seven members of APOBEC3 (A3) family of cytidine deaminases (A, B, C, D, E, F, G and 76 
H) (13–16) catalyze the deamination of cytidine nucleotides to uridine nucleotides in single-strand 77 
DNA substrates. These enzymes are widely acknowledged as fundamental players in the defense 78 
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against various viral infections (14, 15, 17). Since the identification of APOBEC3G (A3G) as a 79 
prototype antiretroviral host restriction factor, A3 subsets have been shown to restrict the replication of 80 
retroviruses (18), endogenous retroelements (19) and, more recently, DNA viruses such as hepatitis B 81 
virus (HBV) (20, 21) and parvoviruses (22, 23). Moreover, different A3 isoforms deaminate human 82 
papillomavirus (HPV) genomes (24) as well as BK polyomavirus (BKV) (25). Genomes of some 83 
herpesviruses, such as herpes simplex virus-1 (HSV-1) and Epstein-Barr virus (EBV), are edited by 84 
APOBEC3 on both strands. Interestingly, the editing is higher on minus strand, possibly due to the fact, 85 
that during discontinued replication the lagging strand exposes more viral ssDNA to nuclear 86 
APOBEC3s than the leading strand. (14–16, 26). Human APOBEC3 proteins are also able to mutate 87 
the genome of the murine Gammaherpesvirus 68 (MHV68) and, therefore, counteract viral replication. 88 
In particular, human A3A, A3B and A3C proved their ability to restrict MHV68 replication (27). 89 
With regard to HCMV, Weisblum et al. (28) have recently reported an important role of 90 
APOBEC3A (A3A) in mediating innate immunity against congenital HCMV infection. In particular, 91 
A3A was strongly upregulated following ex vivo HCMV infection of maternal decidua, and 92 
overexpression of A3A in epithelial cells hampered HCMV replication by inserting hypermutations 93 
into the viral genome through cytidine deamination. A3A induction by HCMV was not observed in 94 
HCMV-infected chorionic villi maintained in organ culture, primary human foreskin fibroblasts (HFFs) 95 
or epithelial cell cultures, suggesting that HCMV-mediated upregulation of A3A is tissue- and cell-type 96 
specific. Intriguingly, IFN-β but not IFN-γ induced A3A expression in uninfected decidual tissues, 97 
suggesting its potential regulation as an IFN-stimulated gene during HCMV infection.  98 
However, there still remain a number of issues that need further investigation. For example, in 99 
contrast to the aforementioned studies, several reports have demonstrated that members of the A3 100 
family are robustly induced in different cell types in vitro and in different tissues in vivo either by IFNs 101 
or viruses (e.g. HIV and HBV). Thus, the question as to whether HCMV is able to induce other A3 102 
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family members besides A3A in different cell types remains open. Another important issue stems from 103 
the observation that HCMV triggers IFN production during the early steps of infection, but it is still 104 
unclear whether A3 induction is mediated by IFN rather than the virus itself. In this respect, IFN 105 
production triggered by HCMV induces expression of IFN-stimulated genes, including the A3 family, 106 
which are committed to restrict virus replication as observed in other viral models. Thus, it is 107 
conceivable that HCMV has developed strategies to escape from APOBEC3 editing activity. Finally, a 108 
major issue concerns APOBEC3 antiviral activity. Although APOBEC3 editing activity has been 109 
reported for all the viruses analyzed, it is still a matter of debate whether this is also true for other 110 
viruses such as influenza viruses, herpesviruses, papillomaviruses and polyomaviruses. Thus, there is a 111 
gap in knowledge concerning the mechanism of HCMV evasion from A3-induced viral genome 112 
mutagenesis. 113 
In the present study, we present evidence that: i) A3G and, to a lower extent, A3F gene products 114 
are induced in HCMV-infected HFFs; ii) the induction of A3G appears to be mediated by IFN-β as it is 115 
drastically decreased upon treatment with anti-IFN type 1 receptor antibodies; iii) neither A3G knock 116 
out nor its overexpression appears to modulate HCMV replication, indicating that A3G does not inhibit 117 
HCMV replication; and iv) A3G exerted a selective pressure that, during evolution has likely shaped 118 
the nucleotide composition of the HCMV genome. 119 
 120 
RESULTS 121 
HCMV infection stimulates various APOBEC3 expression patterns in different cell subsets. To 122 
assess the role of APOBEC3, we first asked whether HCMV infection could regulate mRNA and 123 
protein levels of A3 family members in different cell types. For this purpose, total RNAs from HCMV-124 
infected HFFs, human umbilical vein endothelial cells (HUVECs), macrophages-derived THP-1 or 125 
human retinal pigment epithelial (ARPE-19) cells were extracted at 8 and 24 hours post infection (hpi) 126 
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and subjected to RT-qPCR analysis. Among all A3 family members analyzed, only A3G and A3F 127 
displayed mRNA upregulation in HCMV-infected HFFs compared to mock-infected cells (i.e. ~25 and 128 
~12 fold at 8 hpi; ~10 and ~6 at 24 hpi, respectively) (Fig. 1A). We also observed similar kinetics of 129 
mRNA expression for Mx-1, a well-known IFN-inducible gene (Fig. 1A). Human A3F and human 130 
A3G share more than 90% promoter sequence similarity and appear to be transcriptionally co-regulated 131 
(29, 30). In agreement with these findings, we observed a co-regulated induction of A3G and A3F 132 
expression by HCMV. Notably, A3F and A3G were also induced upon HCMV infection in 133 
differentiated THP-1, although several other members of APOBEC3 family, namely A3A and A3H, 134 
were highly upregulated in this cell line as well. In contrast, mRNA expression levels of all A3 family 135 
members including A3G and A3F remained unchanged in HCMV-infected HUVEC and ARPE-19 136 
cells, whereas Mx-1 mRNA was potently induced (Fig. 1B, C), suggesting that induction of A3G and 137 
A3F is cell-type specific.  138 
HCMV infection induces A3G in HFFs. Since A3G was the most potently induced A3 family 139 
member by HCMV, we decided to focus our attention on this gene in all further analyses. Consistent 140 
with the RT-qPCR results (Fig. 1A), A3G protein expression was significantly upregulated in HCMV-141 
infected HFFs (Fig. 2A). Intriguingly, the kinetics of A3G protein induction, which peaked at 72 hpi, 142 
were delayed relative to those of A3G mRNA which peaked at 8 hpi (Fig. 1A). At the moment, 143 
however, the mechanisms responsible for the delay in protein expression have not been explored. To 144 
get further insight into HCMV-induced A3G DNA deaminase activity, we used an in vitro fluorescence 145 
resonance energy transfer-based oligonucleotide assay (FRET). To this purpose, whole-cell lysates of 146 
mock or HCMV-infected HFFs were incubated with a ssDNA oligonucleotide containing a single CCC 147 
trinucleotide, which represents the canonical deamination target of A3G, along with uracil-DNA 148 
glycosylase (UDG) and RNase A (31). In the presence of A3G cytosine deaminase activity, the 149 
formation of a uracil base results in an abasic site following uracil base excision by UDG. Base 150 
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hydrolysis of the abasic site then releases an FAM signal from the FRET pair. As expected, protein 151 
extracted from HCMV-infected cells displayed deaminase activity consistent with the kinetics of A3G 152 
protein induction, reaching a peak at 72 hpi, when the deamination activity was ~5 fold higher than that 153 
of mock cells (Fig. 2B). Finally, to verify FRET assay specificity, we included an ssDNA 154 
oligonucleotide containing the target motif of A3B (TC) (29) as negative control. As expected, in this 155 
case A3G activity was comparable to mock-infected cells, confirming that A3G is selectively activated 156 
upon HCMV infection (data not shown).  157 
Collectively, these results show that infection of HFFs with HCMV upregulates A3G DNA 158 
deaminase activity in good agreement with the increase of A3G mRNA and protein levels. 159 
Although A3G is typically described as a cytosolic protein (32), several groups have shown that 160 
A3G is also present in the nucleus of different cell lines (33–35). To determine whether subcellular 161 
A3G localization varies during early and late infection with HCMV, we carried out a detailed kinetic 162 
analysis using confocal microscopy at time points ranging from 24 to 72 hpi. HFFs were mock-infected 163 
or infected with HCMV at an MOI of 1, and intracellular localization of A3G was assessed by confocal 164 
microscopy. Consistent with the Western blot results, a substantial accumulation of A3G in the nucleus 165 
of HCMV infected cells was observed at 72 hpi, comparing to the mock-infected cells, where 166 
localization of detected A3G seemed evenly distributed among the cytoplasm and nucleus (Fig. 2C). 167 
Altogether, these results demonstrate that A3G intranuclear localization is enhanced in HCMV-infected 168 
HFFs. 169 
A3G upregulation is IFN-β dependent. The innate immune response against incoming pathogens 170 
plays a key role during primary infection, especially in patients with defects in adaptive immunity. 171 
Early during infection, HCMV triggers type I IFN production, leading to the induction of a number of 172 
IFN-stimulated genes (ISGs), a process that promotes an antiviral state in infected and neighboring 173 
cells (36–39). Stimulation of A3 upon IFN production has been observed in different viral models and 174 
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cell types (40–44). In particular, A3G is strongly induced by IFN-β in response to influenza A virus 175 
infection (43). To assess whether HCMV induces A3G expression through IFN-β induction also in our 176 
model, HFFs were incubated for 24 h in the presence of serial dilutions of IFN-β (50-500 U/ml), and 177 
the mRNA levels of A3G were determined by RT-qPCR (Fig. 3A). As shown in Fig. 3A, IFN-β 178 
stimulation led to over 30-fold induction of A3G mRNA. Likewise, IFN-β treatment of HFFs led to an 179 
increase in A3G protein expression over time, which peaked at the 24 h time point (Fig. 3B). 180 
To definitively prove a causative link between IFN-β production and A3G upregulation, HFFs, 181 
pre-treated for 18 h with anti-IFNAR antibody (Ab) or an isotype control Ab, were infected with 182 
HCMV for 8 h and analyzed by RT-qPCR (Fig. 3C). As expected, suppression of IFN-β production by 183 
anti-IFNAR Ab strongly impaired A3G mRNA induction compared to untreated or isotype control Ab-184 
treated HFFs. Altogether, these results indicate that IFN-β released early during HCMV infection 185 
triggers A3G expression similarly to what reported for other viruses such as orthomyxoviruses and 186 
HPV (43, 44). 187 
HCMV replication is not affected by A3G activity. Several reports have shown that A3G is able to 188 
counteract the replication of HIV-1 (45–51), human T-cell lymphotropic virus type 1 (HTLV-1) (52–189 
56) and HBV (20, 21, 57, 58). In contrast, A3 deaminases do not appear to affect viral replication or 190 
production of infectious viral progeny of two other viruses such as influenza A (43) virus or 191 
polyomavirus (59). Thus, we sought to determine whether A3G acted as a restriction factor for HCMV 192 
replication. For this purpose, CRISPR/Cas9 systems were used to knockout A3G gene in HFFs (A3G 193 
KO) or scrambled control (Scramble CTRL). Western blot analysis confirmed that the majority of cells 194 
were knocked out for A3G. HFFs depleted of A3G were then infected with HCMV at an MOI of 0.1 195 
for 24 h, 72 h, and 144 h, and the viral yield measured by standard plaque assay. As shown in Fig. 4B, 196 
the replication of HCMV was not significantly affected following A3G knock out. 197 
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To further confirm these findings, we transduced HFFs with an adenoviral-derived vector 198 
constitutively expressing A3G protein (AdVA3G) or with a control vector (AdVLacZ) at an MOI of 199 
30. As shown in Fig. 4C AdVA3G efficiently increased the expression of A3G protein compared to 200 
both HCMV or AdVLacZ. After 24 h, cells were infected with HCMV at an MOI of 0.1 for an 201 
additional 24 h, 72h, and 144 h and then analyzed by standard plaque assay. The efficiency of A3G 202 
mRNA and protein overexpression was monitored by Western blot (Fig 4C). Consistent with the 203 
knockout results, A3G overexpression did not exert any antiviral effects on HCMV replication (Fig. 204 
4D), indicating either that A3G is not a restriction factor for HCMV replication or, alternatively, that 205 
HCMV has evolved to escape A3G restriction activity.  206 
A3G-mediated selective pressure shaped the composition of HCMV genome. Because HCMV 207 
infection upregulates A3G expression with no evidence of virus replication restriction, we sought to 208 
determine whether, during evolution, A3G-mediated selective pressure might have played a role in 209 
shaping the composition of HCMV genomes.  210 
A3G preferentially deaminates the 3' cytosine within CCC hotspots in single-stranded DNA 211 
(60, 61), whereas other members of the A3 family have distinct preferences (TTC for A3F and A3C; 212 
TC for A3B and A3H; TCG for A3A) (29, 62–67). We thus assessed the representation of these hotspot 213 
motifs in the HCMV genome using the HCMV Towne sequence, as a detailed functional map of this 214 
strain was constructed by systematic deletion of single open reading frames (ORFs) (68). The 215 
representation of CCC:GGG, TTC:GAA, TCG:CGA and TC:GA motifs was calculated in sliding 216 
windows and compared to the expected counts obtained by randomly shuffling the HCMV genome 217 
sequence (see Methods). Results indicated that the CCC:GGG hotspot is strongly under-represented in 218 
several large genomic regions, whereas no such pattern is observed for the other motifs (Fig. 5). In 219 
particular, the regions where A3G hotspots are under-represented broadly correspond to the genomic 220 
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positions where essential ORFs (i.e. ORFs that impair or strongly reduce HCMV growth in vitro when 221 
deleted) cluster (68).  222 
To date, only one origin of replication (oriLyt) has been described for HCMV (69). By contrast, 223 
the mechanisms of DNA replication remain largely unknown, although a rolling circle phase is likely to 224 
occur (70). When we analyzed the frequency of CCC motifs in the two strands of the viral genomes, we 225 
detected no substantial difference (Fig. 6A), suggesting that the A3G hotspot under-representation is 226 
not mainly determined by preferential deamination of the lagging-strand template (71–74).  227 
Altogether, these observations were consistent with the possibility that HCMV has evolved to 228 
limit CCC:GGG motifs in its genome, especially in essential ORFs. To further address this possibility, 229 
we used an approach that accounts for the coding capacity of the HCMV genome, as well as for the 230 
amino acid composition of single ORFs. In fact, CCC is a codon for proline, and the representation of 231 
this hotspot motif in coding genes also depends on the proline content of the encoded proteins. Thus, 232 
we counted the frequency of the trinucleotide motifs for A3G, A3A, and A3F/A3C in all HCMV ORFs 233 
and obtained expected values by reshuffling codons in each ORF. For each motif in each ORF, we 234 
computed a preference index that varies between -1 (under-representation) and +1 (over-235 
representation), with values close to 0 indicating that the representation of motifs is similar to the 236 
expected one (see Methods). Analysis of preference indexes indicated that CCC:GGG motifs are under-237 
represented in HCMV ORFs and that the median preference index is well below 0. No such pattern was 238 
evident for motifs targeted by other APOBEC3 enzymes, which showed preference indexes close to 0 239 
(Fig. 7A). Also, CCT:AGG motifs, which represent the products of A3G deamination without repair, 240 
were not over-represented in HCMV ORFs, and no negative correlation was observed between the 241 
preference indexes for CCC:GGG and those for CCT:AGG motifs (Fig. 6B). Thus, the under-242 
representation of A3G motifs is not the result of active A3G-mediated deamination and mutation. 243 
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We next sought to determine whether essential and non-essential ORFs displayed a different 244 
representation of APOBEC3G motifs. ORFs were categorized based on the mutant growth 245 
classification proposed by Dunn and co-workers (68) and preference indexes were compared (see 246 
Methods). We found that CCC:GGG motifs are significantly less likely to occur in essential ORFs 247 
compared to non-essential ones (Wilcoxon Rank Sum test, p= 0.014) (Fig. 7B). As selective pressure is 248 
expected to be stronger at essential ORFs, these latter are the most depleted of A3G motifs.  249 
Finally, we verified that the under-representation of CCC:GGG motifs is a general feature of 250 
HCMV genomes and is not limited to the Towne strain. Thus, the preference index for CCC:GGG 251 
motifs was calculated for all ORFs of other HCMV strains (including Merlin) and clinical isolates 252 
deriving from different sources. No substantial differences were observed between the Towne sequence 253 
and any of these strains or isolates (Fig. 7C). Overall, these results suggest that A3G exerted a selective 254 
pressure on HCMV and that the virus evolved to limit A3G hotspots in its genome. 255 
 256 
DISCUSSION 257 
In summary, we report that HCMV infection specifically upregulates A3G and, to a lesser 258 
extent, A3F expression in primary human fibroblasts (HFFs), and that the virus has evolved an escape 259 
strategy to avoid editing activity. Our findings indicate that human A3G is induced upon viral infection 260 
as a part of the antiviral response mediated by IFN-β. In this regard, addition of anti-IFN receptor Abs 261 
during HCMV infection ablates A3G gene product induction demonstrating that A3G induction by 262 
HCMV is IFN dependent. Moreover, IFN-β treatment of HFFs can upregulate A3G expression within 263 
24 h in absence of HCMV infection, confirming that A3G is a bona fide ISG family member. 264 
Accordingly, two IFN-sensitive response elements, namely IFN regulatory factor element (IRF-E)/IFN-265 
stimulated response element (ISRE), located upstream the first A3G exon have been identified (42). 266 
Recently, Weisblum et al. (28) found that A3A is strongly upregulated following ex vivo HCMV 267 
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infection of human decidual tissues but not upon infection of chorionic villi, primary fibroblasts (MRC-268 
5 and HFF), and epithelial (ARPE-19) cell cultures. In line with our results, IFN-β significantly 269 
induced A3A expression in uninfected decidual tissues, suggesting its potential regulation as an ISG 270 
early during HCMV infection. Altogether, these findings demonstrate that A3A and A3G are 271 
differentially regulated in HCMV-infected cells.        272 
In the same study, Weisblum et al. (28) demonstrated that overexpression of A3A severely 273 
impaired HCMV replication in epithelial cells through cytidine deamination of the viral genome. 274 
Moreover, exogenous A3A expression in ARPE-19 cells downregulated the expression of viral genes, 275 
such as immediate early (IE1) and delayed early (UL89) genes, and reduced HCMV DNA 276 
accumulation, suggesting that in this cellular system A3A does restrict virus replication. In contrast to 277 
these observations, here we show that neither knock out nor overexpression of A3G can modulate 278 
HCMV gene expression and its replication, indicating that A3G does not behave as an HCMV 279 
restriction factor in vitro. 280 
Based on this evidence, we hypothesized that during evolution HCMV might have developed 281 
strategies to escape A3G editing activity. To test this hypothesis, we assessed whether A3G-mediated 282 
selective pressure shaped the composition of HCMV genomes. A3G preferentially deaminates the 3’ 283 
cytosine within CCC hotspots in single-stranded DNA, whereas other members of the A3 family have 284 
distinct preferences. Notably, the CCC:GGG motif, but not other A3 motifs, was found to be 285 
significantly under-represented in several genomic regions where essential ORFs are located. The 286 
decrease in CCC:GGG motifs was not paralleled by an increase in their deamination products, and the 287 
A3G hotspot motifs were similarly under-represented in both genome strands. Thus, these observations 288 
suggest that A3G no longer affects the HCMV genome composition because the virus has likely 289 
evolved to limit the presence of A3G hotspot motifs especially within essential ORFs. In this respect, it 290 
is worth mentioning that, albeit under-represented, some CCC:GGG motifs do occur in HCMV ORFs, 291 
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including essential ones. Nevertheless, secondary structures and sequence context are also known to 292 
modulate A3G preferences (75), suggesting that extant CCC motifs could represent sub-optimal targets.  293 
Our findings are in line with previous studies indicating that target motifs for other A3 enzymes 294 
are depleted in the genome of -papillomaviruses, most likely as the result of viral evolution to avoid 295 
restriction (76). Likewise, A3B exerted a selective pressure on BKPyV, which shows an under-296 
representation of hotspot motifs for this enzyme (59). Nonetheless, the specific knockdown of A3B had 297 
little short-term effect on productive BKPyV infection (59).  298 
Recent results have shown that A3A can restrict HCMV replication in human decidual tissues 299 
(28). However, we did not find A3A motifs to be under-represented in HCMV genomes. One possible 300 
explanation for this finding is that decidual tissues do not represent the primary target site of HCMV 301 
infection and vertical transmission, despite being clinically relevant, does not contribute significantly to 302 
HCMV spread in human populations. Thus, the selective pressure exerted by A3A on HCMV may be 303 
limited. In fact, we did not find this enzyme to be upregulated by viral infection in HFFs and other 304 
primary HCMV target cell types.   305 
According to these observations, the following scenario could be envisaged. Early during 306 
HCMV infection DNA sensors including cGAS and IFI16 prime IFN-β production, which in turn 307 
stimulates expression of ISGs including A3G. To prevent DNA editing by A3G from yielding 308 
CCC:GGG hypermutations, the virus has evolved to limit the presence of A3G target motifs in genes 309 
essential for its replication. 310 
Various strategies have been adopted by different viruses to prevent the catastrophic 311 
consequences of A3-induced hypermutations. While several DNA viruses have evolved to limit the 312 
availability of A3 target sites (59, 76), HIV has adopted a completely different evasion strategy based 313 
on the ability of its protein Vif to bind A3G and promote its degradation through the proteasome 314 
pathway (77–80). 315 
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 In conclusion, our studies demonstrate for the first time that: i) early during infection, HCMV 316 
upregulates A3G in fibroblasts (HFFs) through IFN-β production; ii) A3G does not restrict HCMV 317 
replication, and iii) HCMV has evolved mutational robustness against IFN-β by limiting the presence 318 
of A3G hotspots in essential ORFs of its genome. Our findings reveal a novel immune evasion strategy 319 
by HCMV, which further fuels its fame as “master in immune evasion”.     320 
 321 
MATERIALS AND METHODS 322 
Cells and viruses. Primary human foreskin fibroblasts (HFFs, ATCC SCRC-1041™), human retinal 323 
pigment epithelial cells (ARPE-19, ATCC CRL-2302™) and human embryo kidney 293 cells (HEK 324 
293, Microbix Biosystems Inc.) were cultured in Dulbecco’s Modified Eagle’s Medium (Sigma-325 
Aldrich) supplemented with 10% FCS (Sigma-Aldrich) as previously described (81). THP1 cells, 326 
cultured as non-adherent monocyte like cells were grown in RPMI (Sigma-Aldrich), with 10% FCS, 327 
600 μg/ml Glutamine, 200 IU/ml of penicillin and 100μg/ml streptomycin (Gibco). THP1 cells were 328 
differentiated into macrophage like cells by addition of 100nM PMA (Sigma-Aldrich). All presented 329 
data with THP1 cells were based on PMA-differentiated cells. Human umbilical vein endothelial cells 330 
(HUVECs) were isolated from umbilical veins by chymotrypsin treatment and used for experiments at 331 
passage 2±7. HUVECs were cultured in endothelial cell basal medium-2 (EBM-2, Lonza), plus 332 
endothelial cell-growth medium supplements (EGM-2, Lonza), FCS (2%, Sigma-Aldrich) and 333 
penicillin-streptomycin solution (1%, Sigma-Aldrich). HCMV strain Merlin was kindly provided by 334 
Gerhard Jahn (University Hospital of Tübingen, Germany), propagated and titrated on HFFs by 335 
standard plaque assay (12, 39). 336 
Recombinant adenoviral vectors. Adenovirus-derived vectors expressing A3G were generated by 337 
means of a replacement strategy using recombineering methods (82). Briefly, the A3G gene was 338 
amplified using specific set of primers (Forward: 5’-339 
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AACCGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACCGG340 
GACCGATCCAGCCTGGATCCATGAAGCCTCACTTCAGAAA-3’; Reverse: 5’-341 
TATAGAGTATACAATAGTGACGTGGGATCCCTACGTAGAATCAAGACCTAGGAGCGGGTT342 
AGGGATTGGCTTACCAGCGCTGTTTTCCTGATTCTGGAGA-3’). In order to accomplish 343 
homologous recombination, approximately 200 ng of DNA was electroporated into SW102 bacteria 344 
harboring pAdZ5-CV5 vector. Cells were then plated on minimal medium agar plates containing 5% 345 
sucrose and chloramphenicol and incubated at 32°C for 1 day. The colonies that appeared were 346 
inoculated into LB Broth containing ampicillin and chloramphenicol and LB Broth containing 347 
chloramphenicol only. In the colonies grown in chloramphenicol only, the A3G ORF replaced the 348 
ampicilline resistance sequence in multiple cloning sites. Colonies were checked by PCR and 349 
sequencing. To obtain the recombinant adenovirus, the AdZ vector was transfected into HEK 293 350 
packaging cells. Transfected cells were maintained in the 5% CO2 incubator at 37°C until an extensive 351 
cytopathic effect was obtained. Viruses were then purified from infected cultures by freeze-thaw-vortex 352 
cycles and assessed for A3G expression by Western blot. For cell transduction, HFFs were washed 353 
once with PBS and incubated with AdVA3G at an MOI of 30. After 2 h at 37°C, the virus was washed 354 
off and fresh medium applied. For all the experiments, a recombinant adenovirus expressing the E. coli 355 
β-galactosidase gene (AdVLacZ) was used as a control (12). 356 
RNA isolation and semiquantitative RT-qPCR. Total RNA was extracted using the NucleoSpin 357 
RNA kit (Macherey-Nagel) and 1 μg was retrotranscribed using the Revert-Aid H-Minus FirstStrand 358 
cDNA Synthesis Kit (Fermentas), according to the manufacturer’s protocol. Comparison of mRNA 359 
expression between samples (i.e., infected versus untreated) was performed by SYBR green-based RT-360 
qPCR on a Mx3000P apparatus (Stratagene), using the following primers: A3A Fw: 361 
GTCTTATGCCTTCCAATGCC, Rw: GAGAAGGGACAAGCACATGG; A3B Fw: 362 
AATGTGTCTGGATCCATCAGG, Rw: TGAAGGTCAGCAATTCATGC; A3C Fw: 363 
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TCTGCATGACAATGGGTCTC, Rw: AAACTTGGCTGTGCTTCACC; A3D Fw: 364 
GATCTGGAAGCGCCTGTTAG, Rw: AGTCGAATCACAGGCAGGAG; A3F Fw: 365 
CCATAGGCTTTGCGTAGGTT, Rw: AATTATGCATTCCTGCACCG; A3G Fw: 366 
TTCCAAAAGGGAATCACGTC, Rw: AGGGGCTTTCTATGCAACC; A3H Fw: 367 
AGCTGTGGCCAGAAGCAC, Rw: CGGAATGTTTCGGCTGTT; GAPDH Fw 368 
AGTGGGTGTCGCTGTTGAAGT, Rw AACGTGTCAGTGGTGGACCTG; Mx1 Fw: 369 
CCAGCTGCTGCATCCCACCC, Rw AGGGGCGCACCTTCTCCTCA. 370 
Neutralization of type I IFNs. To neutralize the activity of type I IFNs, specific blocking antibodies 371 
against interferon receptor (clone MMHAR-2; Millipore; diluted 1:100) were added to culture media at 372 
a concentration of 5 μg/ml for 18 h prior to infection with HCMV Merlin strain, at an MOI of 1, and 373 
then left in the supernatant until the end of the respective experiment. Mouse IgG2a (clone MOPC-173; 374 
BD Biosciences Europe; diluted 1:100) was used as an isotype control. Human recombinant IFN-β was 375 
obtained from PBL (catalog #11415-1).  376 
Transduction of HFFs with lentiviral CRISPR/Cas9. The CRISPR/Cas9 system was employed to 377 
generate specific gene knockouts in primary human fibroblasts. Recombinant lentiviruses were 378 
packaged in HEK 293T cells by cotransfection of APOBEC3G sgRNA CRISPR/Cas9 All-in-One 379 
Lentivector set (Human) (Applied Biological Materials Inc.) and 2nd Generation Packaging System 380 
Mix (Applied Biological Materials Inc.) for producing viral particles using Lipofectamine 2000 381 
(Invitrogen). Viral supernatants were harvested after 48 h and used to transduce fibroblasts by infection 382 
in the presence of 8 mg/ml Polybrene. Transduced cells were selected with puromycin (1 μg/ml,) over 383 
the course of 14 days postransduction. After selection, successful knockout was confirmed using 384 
immunoblotting. CRISPR negative control lentivirus were produced with Scrambled sgRNA 385 
CRISPR/Cas9 All-in-One Lentivector (Applied Biological Materials Inc.) in HEK293T as described 386 
above. 387 
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Western blot analysis. Whole-cell protein extracts were prepared and subject to Western blot analysis 388 
as previously described (83, 84). The following primary mouse monoclonal antibodies were used: anti- 389 
A3G (VMA00418; Biorad; diluted 1:1000), CMV IEA (CH160; Vyrusis; diluted 1:1000), and α-390 
Tubulin (39527; Active-Motif; diluted 1:4000). Immunocomplexes were detected using sheep anti-391 
mouse antibodies conjugated to horseradish peroxidase (HRP) (GE Healthcare Europe GmbH) and 392 
visualized by enhanced chemiluminescence (Super Signal West Pico; Pierce- Thermo Fischer 393 
Scientific).  394 
Immunofluorescence microscopy. Indirect immunofluorescence analysis was performed as 395 
previously described (83, 85), using the appropriate dilution of primary antibodies for 1 h at RT in the 396 
presence of 10% HCMV negative human serum followed by 1 h incubation with secondary antibodies 397 
in the dark at RT. The following primary antibodies were used: rabbit polyclonal anti-CMV IEA 398 
antibody (Santo Landolfo, University of Turin; diluted 1:500) or mouse monoclonal antibodies anti-399 
A3G (VMA00418; Biorad; diluted 1:200). Conjugated secondary antibodies included: goat anti-rabbit 400 
antibodies Alexa Fluor 568 (A-11011; Life Technologies; diluted 1:200) or goat anti-mouse antibodies 401 
Alexa Fluor 488 (R37120; Life Technologies; diluted 1:200). Nuclei were counterstained with 4',6-402 
diamidino-2-phenylindole (DAPI). Finally, coverslips were mounted with Vectashield mounting 403 
medium (VECTOR). Samples were observed using a confocal microscope (Leica TCS SP2). ImageJ 404 
software was used for image processing.  405 
FRET-based in vitro A3G deamination assay. A fluorescence resonance energy transfer (FRET) 406 
based assay was used to detect cytosine deaminase activity of A3G (75). Twenty µl of the cell lysates 407 
were used per assay using 96 assay plates. A separate solution of 20 pmoles of oligonucleotide, 10 µg 408 
RNase A and 0.04 U uracil DNA glycosylase (UDG) were mixed together in 50 mM Tris pH 7.4, 10 409 
mM EDTA buffer and adjusted to a total volume of 50 µl, and then transferred to the assay well. The 410 
assay plate was then incubated at 37°C for 5 h. Next, 30 µl of 2 M Tris-acetate, pH 7.9 was added to 411 
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each well, and the plate was incubated at 95°C for 2 min and on ice for 2.5 min. The fluorescence was 412 
then measured at room temperature using a VICTOR
3
 1420 Multilabel Counter (Perkin–Elmer). 413 
Experiments were conducted with three independent replicates.  414 
Statistical analysis. Statistical tests were performed using GraphPad Prism version 5.00 for Windows 415 
(GraphPad Software), unless specified differently in the text. The data were presented as means ± 416 
standard deviations (SD). Means between two or three groups were compared by using a one-way or 417 
two-way analysis of variance with Bonferroni’s post-test. Differences were considered statistically 418 
significant for *, P<0.05; **, P<0.01; ***, P<0.001. 419 
Analysis of A3 hotspot motif representation. HCMV genome sequences were obtained from the 420 
GenBank database. To evaluate the genomic representation of A3 hotspots, we counted the number of 421 
each A3 motif in 1000 bp windows along the HCMV Towne genome, using a sliding window approach 422 
with a step of 100 bp, on both genome strands. To assess whether this count is an under- or an over-423 
representation of A3 motifs, we generated 1000 shuffled versions of each window and counted the 424 
number of each motif within these windows. The number of these occurrences was then used to create 425 
distributions of motif counts (in each window), and the percentile rank of the true motif count was 426 
calculated. These percentile ranks are plotted in Fig. 5. For instance, a rank of 0 in a window indicates 427 
that the real number of motif counts was lower than all those obtained in reshuffled versions of that 428 
same window.  429 
To investigate the distribution of A3G motifs in the HCMV genome by also accounting for 430 
coding capacity and amino acid composition, we counted the frequency of motifs in each HCMV ORF. 431 
We then obtained expected values by reshuffling codons in each ORF; specifically, for each ORF, we 432 
generated 1000 codon-shuffled sequences. We next calculated a preference index for A3 motifs, 433 
defined as follows: preference index= (motifs observed-motifs expected)/ (motifs observed + motifs 434 
expected). In practical terms, the preference index varies between -1 and +1, with values equal to 0 435 
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indicating that the representation of motifs is equal to the expected; negative and positive values 436 
indicate under- and over-representation, respectively. ORFs were grouped based on the Mutant Growth 437 
Classification proposed by Dunn et. al (68): essential (“no growth” and “severely defective”) and non-438 
essential (“moderately defective” and “like wild type”). 439 
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FIG 1 Apolipoprotein B editing enzyme catalytic subunit 3 (APOBEC3) gene expression patterns in 680 
human cytomegalovirus (HCMV)-infected cells. Primary human foreskin fibroblasts (HFFs) (A), 681 
human umbilical vein endothelial cells (HUVECs) (B), differentiated THP1-1 cells (THP-1 682 
macrophages) (C) or human retinal pigment epithelial cells (ARPE-19) (D) were infected with HCMV 683 
at an MOI of 1 and subject to RT-qPCR to measure mRNA expression of various APOBEC3 family 684 
members (i.e. A3A, A3B, A3C, A3DE, A3F, A3G and A3H) and Mx-1. Values were normalized to the 685 
housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA, and plotted as a 686 
fold induction relative to mock-infected cells. Data are presented as mean values of biological 687 
triplicates. Error bars show standard deviations, (*, P< 0.05; **, P< 0.01; one-way ANOVA followed 688 
by Bonferroni’s post-tests, for comparison of infected versus mock cells). 689 
 690 
FIG 2 HCMV infection upregulates A3G in HFFs. (A) Lysates were prepared at the indicated time-691 
points and subject to Western blot analysis for A3G, IEA and α-Tubulin (left panel). A3G protein was 692 
subject to densitometry and normalized to α-Tubulin (*, P< 0.05; ***, P< 0.001; one-way ANOVA 693 
followed by Bonferroni’s post-tests, for comparison of infected versus mock cells) (right panel). (B) 694 
FRET assay to measure A3G deaminase activity. The average and standard deviation were calculated 695 
from three independent experiments (**, P< 0.01; ***, P< 0.001; one-way ANOVA followed by 696 
Bonferroni’s post-tests, for comparison of infected versus mock cells). RFU, relative fluorescence 697 
units. (C) HFFs were infected with HCMV at an MOI of 1, or left uninfected (mock) and subject to 698 
immunofluorescence analysis at the indicated time-points. A3G (green)/IEA (red) were visualized 699 
using primary antibodies followed by secondary antibody staining in the presence of 10% HCMV-700 
negative human serum. Nuclei were counterstained with DAPI (blue). Images were acquired at X63 701 
magnification, and representative pictures are shown. 702 
 703 
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FIG 3 APOBEC3G upregulation is IFN-β dependent. (A) HFFs were stimulated for 24 h with the 704 
indicated doses of IFN-β, and the mRNA levels of A3G were determined by means of RT-qPCR. 705 
Values were normalized to GAPDH mRNA and plotted as fold induction relative to untreated HFFs. 706 
(B) Western blot analysis to assess APOBEC3G protein levels and α-Tubulin upon IFN-β treatment 707 
(1000 U/ml) for the indicated time points (hpt, hours post treatment). One representative experiment of 708 
three performed in duplicate is shown. (C) HFFs were mock- and HCMV-infected in the presence of an 709 
anti-IFNAR antibody (5 µg/ml) or isotype control. At 8 hpi, cells were processed by RT-qPCR to 710 
assess A3G expression. Data presented in (A) and (C) are mean values of biological triplicates. Error 711 
bars show standard deviations (*, P< 0.05; **, P< 0.01; one-way ANOVA followed by Bonferroni’s 712 
post-tests, for comparison of treated versus untreated cells).  713 
 714 
FIG 4 A3G is not a restriction factor for HCMV replication. (A) Knockout gene variants in HFFs for 715 
A3G (A3G KO) and the scramble control, were generated with CRISPR-Cas9 technology. The 716 
efficiency of A3G depletion was measured by Western blot analysis for A3G and -Tubulin. (B) A3G 717 
KO HFFs were infected with HCMV at an MOI of 0.1. The extent of virus replication was measured at 718 
the indicated times post-infection by titrating the infectivity of supernatants and cell suspension on 719 
HFFs by standard plaque assay. Results are expressed as means ± SD. (C) HFFs were transduced with 720 
AdVA3G or AdVLacZ at an MOI of 30 PFU/cell. The efficiency of A3G overexpression was measured 721 
by Western blot analysis for A3G and -Tubulin. (D) HFFs were transduced with AdV vectors as 722 
described in (C). Subsequently, cells were infected with HCMV at an MOI of 0.1. The extent of virus 723 
replication was measured at the indicated times post-infection as described in (B). Results are 724 
expressed as means ± SD.  725 
FIG 5 Sliding window analysis of APOBEC3 hotspot motifs along the HCMV genome. The HCMV 726 
Towne sequence was used (GenBank Accession: GQ121041). Motifs were analyzed in 1000 bp 727 
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windows moving with a step of 100 bp. For each window, the percentile rank of the real motif count in 728 
the distribution of counts from reshuffled windows is plotted. The lower the percentile rank, the fewer 729 
motifs are detected in the window when base composition is accounted for (by reshuffling). A 730 
schematic representation of HCMV open reading frames (ORFs) is shown with color codes indicating 731 
essential ORFs (red), non-essential ORFs (green) and ORFs with unknown effect when deleted (grey). 732 
 733 
FIG 6 Occurrence of APOBEC3G motif in HCMV. (A) Sliding window analysis of APOBEC3G 734 
hotspot motif along the HCMV genome. APOBEC3G motif (CCC) was analyzed for both strands in 735 
1000 bp windows moving with a step of 100 bp. For each window, the percentile rank of the real motif 736 
count in the distribution of counts from reshuffled windows is plotted. The HCMV Towne sequence 737 
was used (GenBank Accession: GQ121041). (B) CCC/CCT motifs comparison. Preference Index 738 
calculated for the CCC:GGG motif is plotted against the Preference Index for the CCT:AGG motif, 739 
both calculated for Essential (red) and Non Essential (blue) Towne ORFs. Spearman's rank correlation 740 
coefficient (rho) is also reported, along with the correlation P value. 741 
 742 
FIG 7 Occurrence of APOBEC3 motifs in HCMV ORFs. (A) The occurrence of hotspot motifs for 743 
A3G, A3F/3C and A3A was analyzed by calculating a preference index. Preference indexes are shown 744 
in standard box-and-whisker plot representation (thick line: median; box: quartiles; whiskers: 1.5 x 745 
interquartile range). The Kruskal-Wallis tests indicated significant differences among motifs 746 
(p<2.2x10
-16
). P values from post hoc tests (Nemenyi tests) are shown. N.S., not significant. (B) 747 
Occurrence of A3G hotspot motifs in HCMV essential and non-essential ORFs. Essential ORFs have 748 
significantly fewer CCC:GGG motifs compared to non-essential ORFs (P value from Wilcoxon Rank 749 
Sum test). (C) Occurrence of A3G hotspot motifs in different HCMV strains and isolates. The 750 
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preference indexes of Towne ORFs are plotted against the corresponding indexes from other HCMV 751 
genomes. Isolate derived from different sources or body compartments were analyzed. 752 
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